GeoVax Labs, Inc. (GOVX) Financials
GOVX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 9.3 million | 3.5 million |
2023-09-30 | 16.2 million | 7.1 million |
2023-06-30 | 21.2 million | 4.1 million |
2023-03-31 | 27.4 million | 4.5 million |
GOVX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -10.3 million | 261458 |
2023-09-30 | -5.1 million | 297947 |
2023-06-30 | -6.1 million | 269513 |
2023-03-31 | -3.8 million | 246039 |
GOVX Net Income
No data available :(
GOVX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 6.5 million | - | - |
2023-09-30 | 12.7 million | - | - |
2023-06-30 | 17.8 million | - | - |
2023-03-31 | 23.9 million | - | - |
GOVX Shares Outstanding
GOVX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 18949 | 6.2 million | 1.5 million | -6.0 trillion |
2023-09-30 | 6192 | 6.9 million | 1.7 million | - |
2023-06-30 | 23805 | 4.7 million | 1.5 million | - |
2023-03-31 | 23805 | 2.8 million | 1.5 million | - |
GOVX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 103912 | 22213 |
2023-09-30 | - | 17319 |
2023-06-30 | - | 17318 |
2023-03-31 | - | 17319 |
GOVX
Price: $1.42
52 week price:
Earnings Per Share: -14.29 USD
P/E Ratio: -0.18
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 421264
Market Capitalization: 3.7 million